Connect
← Return to Just Diagnosed with Small Fiber Neuropathy
Discussion
Just Diagnosed with Small Fiber Neuropathy
Neuropathy | Last Active: Jul 4, 2023 | Replies (235)Comment receiving replies
@jakedduck1 @lorirenee1
I don't remember what he said about the hallucinations and I doubt Linda does as she has not mentioned it ever. Her hallucinations were not scary but were very real seeming. She described them as cartoony bubble men floating around her and making faces and doing various antics. She said had they been scary critters, since they were so real, pretty much anyone would probably stop the gabapentin for that alone. She found it a strange phenomenon. I'm not sure I ever heard before that if you keep taking it long enough some of the symptoms subside, and I'm not really sure we knew all that much about the drug while she was taking it. But it was over two years ago now and ancient history in our book.
Best to you both, Hank
Replies to "@jakedduck1 @lorirenee1 I don't remember what he said about the hallucinations and I doubt Linda does..."
Connect
@jesfactsmon
Chemo-Induced Peripheral Neuropathy: Quality of Life and Treatment Planning
The Foundation for Peripheral Neuropathy is bringing together a panel of experts for this webinar to discuss CIPN and its impact on patients and their physical and mental health.
https://www.foundationforpn.org/events/?blm_aid=116106
Date: November 10, 2020
Time: 12:00 PM – 1:00 PM ET (Please note that this lecture starts at 11 a.m. Central, 10 a.m. Mountain and 9 a.m. Pacific)
REGISTER NOW - https://register.gotowebinar.com/register/5174813403335669772
Panelists for the webinar are:
Thomas Smith, MD FACP FASCO FAAHPM
Professor of Oncology,
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Stefanie Geisler, MD
Assistant Professor, Neurology,
Washington University, St Louis, MO
Krista Nelson, LCSW, OSW-C, Oncology Social Worker
Providence Health Systems
CIPN (Chemo-Induced Peripheral Neuropathy) can be an unexpected side-effect of certain breast and other cancer treatments. While the treatments save lives, the resulting CIPN can be life-changing and devastating.
CIPN, depending on its severity, may impact future treatment decision-making requiring effective doctor-patient communication about future options and goals of therapy. Patients often find it difficult to find information about CIPN and are at a loss as to how to discuss treatment options with their medical care providers. Patients are equally unaware of the impact on their ongoing mental health that CIPN can cause.
The panelists will provide the latest information about the causes and treatments of CIPN, offer insight into the patient-doctor relationship, and explore the emotional challenges and medical options in coping with CIPN. The webinar will conclude with a Q&A session.
This webinar is generously sponsored by:
The Foundation for Peripheral Neuropathy
485 Half Day Road, Suite 350
Buffalo Grove, IL 60089
847-883-9942
http://www.foundationforpn.org